Improve global health by co-designing the future of healthcare for patients WITH patients.
Patient Focused Medicines Development (PFMD) aims to transform the way in which we understand, engage, and partner with patients globally in the design and development of research and medicines by focusing on unmet patient needs. We are bringing together and synergising disparate but complementary efforts that integrate the voice of the PATIENT across the lifecycle of medicine. PFMD was established in October 2015 as an open, independent global coalition of health stakeholders.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Other 19 May 2023 | | |
Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 30 Nov 2023 | |